Injective's audience is building financial products, not applications.
Injective is a finance specific chain, and the projects that matter here are exchanges, derivatives venues and structured products. The people evaluating you think in terms of execution quality, settlement and counterparty risk. General purpose crypto marketing does not reach them, and financial marketing carries rules that general crypto marketing ignores.
Three things that are different about launching on Injective.
Generic launch advice is worth very little once a chain is chosen. These are the constraints that actually shape the work on Injective.
Your reader thinks like a desk
Execution, settlement, slippage and risk are the vocabulary. Material that leads with ecosystem and community language signals you are not building for this audience.
Financial claims carry regulatory weight
Describing a derivatives product is not the same as describing an app. Language about returns, hedging and risk has legal consequences and needs review as a matter of course.
Interoperability is part of the pitch
Cosmos connectivity and cross chain assets shape what is possible here, and explaining where liquidity comes from is usually a necessary part of the story.
What we will tell you before you commit.
Financial products attract regulatory attention, and marketing copy is evidence. Anything that reads as investment advice or a return promise is a liability regardless of intent.
We take no foundation retainers and no ecosystem referral fees on any chain, including Injective. If Injective is the wrong choice for what you are building, you will hear that during the scoping call rather than after the invoice.
Where our work stops
We do not write, deploy or audit smart contracts. We do not provide market making, treasury management or token economics as a financial service, we do not give financial, investment, tax or legal advice, and we cannot guarantee an exchange listing. What we do is everything around the contract: positioning, brand identity, the litepaper, the launch site, the dApp front end, the investor and community material and the campaign that carries it.
What the program covers.
Brand and narrative, litepaper and investor material, the launch site and dApp front end, community architecture and the listing kit. The deliverables are the same wherever you launch. What changes on Injective is the emphasis, and that is what the sections above are about. Full scope and engagement shapes.
Injective launch questions we get asked.
Do you build the exchange or matching engine?
No. We do not write, deploy or audit contracts and we do not build matching engines. We handle brand, interface design, front end and communications.
Can we describe expected returns?
No. We will not put projected returns, target yields or implied floors in marketing material, and we would encourage your counsel to take the same view.
Why do teams choose Injective?
Finance specific infrastructure, order book support and Cosmos interoperability. Whether it beats a general purpose chain depends on your product and where your liquidity comes from.
Do you work with our compliance team?
Yes, and for financial products we assume review cycles are part of the schedule rather than an obstacle to it.
Nothing on this page is financial, investment, tax or legal advice. Orca Web3 provides marketing, branding and design services only. Injective and other chain names and logos are the trademarks of their respective owners and appear here to indicate the networks we work on, not to imply endorsement or partnership.
Tell us what you are launching on Injective.
A scoping call costs nothing and ends with a straight answer, including the answer that Injective is the wrong chain for this or that you do not need a token at all.